Literature DB >> 14982198

The internist's role in managing diabetic retinopathy: screening for early detection.

Stephen H Sinclair1, Cherie Delvecchio.   

Abstract

Although laser treatment keeps vision damaged by diabetic retinopathy from becoming worse, it only rarely improves vision. If primary care physicians wait until the patient complains of blurred vision, it is too late--there is already permanent retinal injury, and the lost vision almost never can be restored. Unfortunately, only half of patients with diabetes undergo an appropriate examination every year. Only by teamwork between primary care physician and ophthalmologist can blindness from diabetic retinopathy be reduced.

Entities:  

Mesh:

Year:  2004        PMID: 14982198     DOI: 10.3949/ccjm.71.2.151

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  5 in total

1.  Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes.

Authors:  Kousuke Noda; Shintaro Nakao; Souska Zandi; Verena Engelstädter; Yukihiko Mashima; Ali Hafezi-Moghadam
Journal:  Exp Eye Res       Date:  2009-07-25       Impact factor: 3.467

2.  Transitioning to a clinical practice model in your local environment.

Authors:  Timothy P Murphy; Gregory M Soares
Journal:  Semin Intervent Radiol       Date:  2005-03       Impact factor: 1.513

3.  The potential for interventional radiologists of peripheral arterial disease.

Authors:  Timothy P Murphy; Gregory M Soares
Journal:  Semin Intervent Radiol       Date:  2005-03       Impact factor: 1.513

4.  Primary care physicians' knowledge of the ophthalmic effects of diabetes.

Authors:  Michael N Wiggins; Reid D Landes; Swetangi D Bhaleeya; Sami H Uwaydat
Journal:  Can J Ophthalmol       Date:  2013-08       Impact factor: 1.882

5.  Diabetic Retinopathy-An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes.

Authors:  Stephen H Sinclair; Stanley S Schwartz
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-13       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.